导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -15.53% | 4112/4773 |
| 近一周 | -4.15% | 4849/5462 |
| 近一月 | -6.84% | 3642/5421 |
| 近一季 | -2.04% | 1145/5209 |
| 近半年 | -17.47% | 4191/4920 |
| 近一年 | -19.70% | 3925/4366 |
| 近两年 | 20.22% | 2643/2954 |
| 近三年 | -21.51% | 2172/2253 |
| 成立以来 | -7.41% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.68% 2427/4961 |
-17.49% 4769/5312 |
- - |
- - |
| 2025 | 8.43% 2901/4813 |
10.06% 348/3635 |
2.21% 1757/4076 |
-0.68% 3936/4524 |
-2.95% 3235/4813 |
| 2024 | -12.27% 2369/3463 |
-11.31% 2423/2808 |
-15.00% 2696/3014 |
18.41% 1010/3129 |
-1.72% 1805/3463 |
| 2023 | -7.71% 941/2656 |
13.94% 256/2280 |
-9.22% 2047/2385 |
-9.10% 1777/2515 |
-1.85% 381/2655 |
| 2022 | -16.75% 511/2207 |
-21.93% 1669/1919 |
0.31% 1561/2016 |
-9.79% 309/2113 |
17.84% 47/2208 |
| 2021 | 5.83% 534/1822 |
-0.07% 328/1255 |
2.75% 991/1330 |
-8.33% 1129/1466 |
12.44% 81/1822 |
| 2020 | 16.72% 772/1250 |
4.63% 64/1028 |
20.09% 285/1067 |
-1.36% 1064/1164 |
-5.82% 1140/1184 |
| 2019 | 33.72% 427/1092 |
30.88% 225/754 |
-7.98% 577/804 |
5.76% 136/850 |
4.99% 760/918 |
| 2018 | -17.87% 135/834 |
- - |
- - |
- - |
-15.12% 599/691 |
| 2017 | -8.39% 527/714 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 汇添富中证互联网医疗指数(LOF)C VS. 长安沪深300非周期A(740101) |